Skip to main content

Mark Rendell

Subscribe Register My account My account AdChoices

Mark Rendell

Staff
Reporter
Cannabis Industry Reporter
Toronto, Canada
mrendell@globeandmail.com
Mark Rendell is a reporter for The Globe and Mail.
Mark Rendell abides by The Globe and Mail Editorial Code of Conduct
Latest articles
Report on Business Cannabis Professional
Supreme looks to wellness market with Blissco acquisition
Cannabis Professional content
Report on Business Cannabis Professional
Takeaways from Tuesday’s triple earnings
Cannabis Professional content
Report on Business Cannabis Professional
Micro madness: How B.C.’s craft cannabis industry is losing out on legalization
Cannabis Professional content
Report on Business Cannabis Professional
Health Canada’s licence overhaul: Key takeaways
Cannabis Professional content
Cannabis
Hemp growers, food makers press Ottawa to reclassify CBD as a natural health product
Subscriber content
Report on Business Cannabis Professional
What you need to know about the nursery licence
Cannabis Professional content
Report on Business Cannabis Professional
OSC issues cease-trade order for Wayland
Cannabis Professional content
Report on Business Cannabis Professional
Policing pot stock promotion: a conversation with OTC Markets Group
Cannabis Professional content
Report on Business Cannabis Professional
Canopy’s C3 acquisition solidifies European and pharma strategy
Cannabis Professional content
Report on Business Cannabis Professional
B.C. securities regulator joins with Ontario to increase scrutiny of the CSE
Cannabis Professional content
Report on Business Cannabis Professional
Newstrike spoke mostly with non-cannabis co.’s before settling on HEXO deal
Cannabis Professional content
Report on Business Cannabis Professional
‘We’re still bullish on Canadian cannabis.’ Q&A with Elliot Johnson of Evolve
Cannabis Professional content
Cannabis
Canopy pays $300-million to secure right to buy Acreage Holdings
Subscriber content
Report on Business Cannabis Professional
Invest in management teams: takeaways from the GMP Securities investor panel
Cannabis Professional content
Cannabis
Investors punish Aphria as quarterly pot sales disappoint in wake of legalization
Subscriber content
Report on Business Cannabis Professional
Cannabis science still in its infancy, Toronto researchers say
Cannabis Professional content
updated
Aurora, Aphria, Wayland secure German cultivation, companies say
Cannabis Professional content
Report on Business Cannabis Professional
MediPharm pursues white-label strategy for non-cannabis clients
Cannabis Professional content
Report on Business Cannabis Professional
Forgotten, but not gone: Why convertible debentures are a ticking debt bomb for underperforming pot co.'s
Subscriber content
Cannabis
Customers line up for blocks as legal cannabis retailers open doors in ‘whirlwind’ piecemeal rollout
Subscriber content